Stereotactic body radiation therapy: scope of the literature
- PMID: 21536933
- DOI: 10.7326/0003-4819-154-11-201106070-00343
Stereotactic body radiation therapy: scope of the literature
Abstract
Stereotactic body radiation therapy (SBRT) is derived from the techniques of stereotactic radiosurgery used to treat lesions in the brain and spine. It combines multiple finely collimated radiation beams and stereotaxy to deliver a high dose of radiation to an extracranial target in the body in a single dose or a few fractions. This review provides a broad overview of the current state of SBRT for solid malignant tumors. Reviewers identified a total of 124 relevant studies. To our knowledge, no published comparative studies address the relative effectiveness and safety of SBRT versus other forms of external-beam radiation therapy. Stereotactic body radiation therapy seems to be widely diffused as a treatment of various types of cancer, although most studies have focused only on its use for treating thoracic tumors. Comparative studies are needed to provide evidence that the theoretical advantages of SBRT over other radiation therapies actually occur in the clinical setting; this area is currently being studied in only 1 small trial.
Similar articles
-
Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.Oncologist. 1997;2(1):59-61. Oncologist. 1997. PMID: 10388030
-
Helical tomotherapy-based STAT stereotactic body radiation therapy: Dosimetric evaluation for a real-time SBRT treatment planning and delivery program.Med Dosim. 2010 Winter;35(4):312-9. doi: 10.1016/j.meddos.2010.08.002. Med Dosim. 2010. PMID: 21055611
-
Stereotactic Body Radiation Therapy [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 May. Report No.: 10(11)-EHC058-EF. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 May. Report No.: 10(11)-EHC058-EF. PMID: 21735562 Free Books & Documents. Review.
-
Stereotactic body radiation therapy (SBRT) in pancreatic cancer: is it ready for prime time?JOP. 2008 Nov 3;9(6):676-82. JOP. 2008. PMID: 18981547
-
Stereotactic body radiation therapy. Rationale, techniques, applications, and optimization.Oncology (Williston Park). 2004 Oct;18(11):1419-30; discussion 1430, 1432, 1435-6. Oncology (Williston Park). 2004. PMID: 15609470 Review.
Cited by
-
Human enteroids as a tool to study conventional and ultra-high dose rate radiation.Integr Biol (Camb). 2023 Apr 11;15:zyad013. doi: 10.1093/intbio/zyad013. Integr Biol (Camb). 2023. PMID: 37874173 Free PMC article.
-
Nanotechnology-based radiation therapy to cure cancer and the challenges in its clinical applications.Heliyon. 2023 Jun 13;9(6):e17252. doi: 10.1016/j.heliyon.2023.e17252. eCollection 2023 Jun. Heliyon. 2023. PMID: 37389057 Free PMC article. Review.
-
Adverse Events Following Limited Resection versus Stereotactic Body Radiation Therapy for Early Stage Lung Cancer.Ann Am Thorac Soc. 2022 Dec;19(12):2053-2061. doi: 10.1513/AnnalsATS.202203-275OC. Ann Am Thorac Soc. 2022. PMID: 35816617 Free PMC article.
-
Hypo-fractionation radiotherapy normalizes tumor vasculature in non-small cell lung cancer xenografts through the p-STAT3/HIF-1 alpha signaling pathway.Ther Adv Med Oncol. 2020 Oct 29;12:1758835920965853. doi: 10.1177/1758835920965853. eCollection 2020. Ther Adv Med Oncol. 2020. Retraction in: Ther Adv Med Oncol. 2023 Apr 3;15:17588359231165586. doi: 10.1177/17588359231165586. PMID: 33193827 Free PMC article. Retracted.
-
Stereotactic Body Radiation Therapy and Ablative Therapies for Solid Tumors: Recent Advances and Clinical Applications.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819830720. doi: 10.1177/1533033819830720. Technol Cancer Res Treat. 2019. PMID: 30922170 Free PMC article. No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources